DOCSLIB.ORG

Public Assessment Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Public Assessment Report Public Assessment Report Scientific discussion Montek Radionuclide generator, 10-40 GBq Sodium (99Mo) molybdate/sodium pertechnetate (99mTc) DK/H/1741/001/DC Date: 17 June 2013 This module reflects the scientific discussion for the approval of Montek. The procedure was finalised on 13 April 2011. For information on changes after this date please refer to the module ‘Update’. I. INTRODUCTION Based on the review of the quality, safety and efficacy data, the Member States have granted a marketing authorisation for Montek radionuclide generator, 10-40 GBq, from Monrol Europe S.R.L. The eluate from the generator (sodium pertechnetate (99mTc) injection Ph. Eur.), may be used as a reagent for labelling of various carrier compounds supplied as kits or administered directly in-vivo. When administered intravenously, the sterile sodium (99mTc) pertechnetate solution is used as a diagnostic aid in the following: Thyroid scintigraphy: Direct imaging and measurement of thyroid uptake to give information on the size, position, nodularity and function of the gland in thyroid disease. Salivary gland scintigraphy: To assess salivary gland function and duct patency. Location of ectopic gastric mucosa: Meckel’s diverticulum. Cerebral scintigraphy: To identify breaches in the blood-brain barrier caused by tumour, infarction, haemorrhage and oedema, when no other methods are available. Following instillation of sterile sodium pertechnetate (99mTc) solution into the eye, the product may be used for Lacrimal duct scintigraphy to assess patency of tear ducts. A comprehensive description of the indications and posology is given in the SmPC. This decentralised procedure concerns a generic application claiming essential similarity with the reference product Drytec which has been registered in Denmark by GE Healthcare Limited since 1995. The marketing authorisation has been granted pursuant to Article 10.3 of Directive 2001/83/EC. II. QUALITY ASPECTS II.1 Introduction The mother nuclide is sodium (99Mo) molybdate 10-40 GBq/generator (no carrier added) at the activity reference date. The daughter nuclide is sodium (99mTc) pertechnetate 8.3-33.9 GBq. The quantity of sodium pertechnetate (99mTc) injection, Ph. Eur. that may be eluted from the generator at any one time is dependent on the quantity of sodium (99Mo) molybdate present, the volume of eluate obtained and the elapsed time since the previous elution. Technetium-99m is produced by means of a (99Mo/99mTc) generator and decays with the emission of gamma radiation with a mean energy of 140 keV and a half-life of 6 hours to 99mTc which, in view of its long half-life of 2.13 x 105 years can be regarded as quasi stable. The radionuclide generator is a blue colour plastic covered cylindrical body and closure, attached to the body with 2 clamps, with a holder on top. The radionuclide generator is supplied in a type I, colourless, natural glass column with bromobutyl rubber stopper and aluminium cap. The evacuated vial is a 20 ml colourless, type I natural glass vial with bromobutyl rubber stopper and aluminium cap. The sodium chloride 9 mg/ml (0.9%) solution for injection is supplied in colourless, 20 ml, type I natural glass vials and bromobutyl rubber stoppers with aluminium caps. The outer container consists of a tin bucket with the aid of styrofoam filling material and contains: Radionuclide generator: Lead shield in plastic outer container. Evacuated vial: Cardboard box Sodium chloride 9 mg/ml (0.9%) solution for injection of 5 ml, 10 ml: Cardboard box. The sodium chloride 9 mg/ml (0.9%) solution for injection eluent is available in 2 different volumes giving elution volumes of 5 ml and 10 ml to allow the generator eluate to be collected at varying radioactive concentrations. Packs of 5 vials containing 5 ml and 5 vials containing 10 ml of sodium chloride 9 mg/ml (0.9%) solution for injection. Packs of 10 vials containing 5 ml sodium chloride 9 mg/ml (0.9%) solution for injection or 10 vials containing 10 ml sodium chloride 9 mg/ml (0.9%) solution for injection are available for custom order. Vials are packed in 5 vial cartons. Evacuated elution vials are available in packs of 10 vials. Vials are packed in 5 vial cartons. However, not all pack sizes may be available. The excipients are: Aluminium oxide; Molybdenum trioxide; Sodium hydroxide; Hydrogen peroxide 30%; Sodium hydroxide 1 M (pH adjustment); Hydrochloric acid 4 M (pH adjustment); Hydrochloric acid 1 M (pH adjustment); Sodium chloride 9 mg/ml (0.9%) solution for injection and Water for injections. Compliance wih Good Manufacturing Practice The RMS has been assured that acceptable standards of GMP (see Directive 2003/94/EC) are in place for this product type at all sites responsible for the manufacturing of the active substance as well as for the manufacturing and assembly of this product prior to granting its national authorisation. II.2 Drug Substance The generator contains sodium molybdate (99Mo) sourced from two suppliers. The documentation from the two suppliers is presented as European Drug Master Files (EDMF) in CTD format. In both cases the molybdenum (99Mo) is extracted from fission products of uranium. Since the filing of the two DMFs an EP monograph on sodium molybdate (99Mo) solution (fission) has been published. On the basis of the current drug master files and the documentation submitted during the procedure sodium molybdate (99Mo) complies with the Ph.Eur. monograph 01/2008:1923, sodium molybdate 99Mo solution (fission). The manufacture and control of the drug substances are in accordance with guidelines and described adequately. Stability studies have been performed with the drug substances. No significant changes in any parameters were observed. Appropriate retest periods have been set. II.3 Medicinal Product The product is a sodium molybdate (99Mo)/sodium pertechnetate (99mTc) generator, under the trade name Montek radionuclide generator, 10-40 GBq; the daughter nuclide in the form of sodium pertechnetate (99mTc) is obtained from molybdenum extracted from fission products of uranium. The documentation provided complies with relevant EU guidelines and directives. Manufacture is performed in accordance with cGMP and specifications for sodium pertechnetate (99mTc) injection eluated from Montek (99Mo) generator comply with Ph.Eur. monograph 01/2008:0124, sodium pertechnetate (99mTc) injection (fission). Sodium chloride 9 mg/ml (0.9%) solution for injection is controlled adequately in accordance with Ph.Eur. methods. The following shelf-lives and storage conditions have been set: Montek generator: 21 days from the date of manufacture. Store the generator below 25°C in the original package. Do not freeze. Eluate: 8 hours from elution. Store the eluate, sodium pertechnetate (99mTc) injection below 25°C in the original package. Do not freeze. Evacuated vials: 12 months without storage conditions. Sodium chloride 9 mg/ml (0.9%) solution for injection: 12 months. III. NON-CLINICAL ASPECTS This product is a generic formulation of Drytec, which is available on the European market. No new preclinical data have been submitted, and therefore the application has not undergone preclinical assessment. This is acceptable for this type of application. Overview based on literature review is, thus, appropriate. The non-clinical overview on the pre- clinical pharmacology, pharmacokinetics and toxicology is adequate. IV. CLINICAL ASPECTS This product is a generic formulation of Drytec, which is available on the European market. No new clinical data have been submitted, and therefore the application has not undergone clinical assessment. This is acceptable for this type of application. The clinical overview on the clinical pharmacology, efficacy and safety is adequate. IV.1 Risk management plan & Pharmacovigilance system 99Mo/99mTc (Tc generator) was first approved in 1983, and there is now more than 10 years post- authorisation experience with the use of 99Mo/99mTc (Tc generator). The safety profile of 99Mo/99mTc can be considered to be well established and no product specific pharmacovigilance issues were identified pre- or postauthorisation which are not adequately covered by the current SPC. Additional risk minimisation activities have not been identified for the reference medicinal product. The MAH has a pharmacovigilance system at their disposal, which is based on the current European legislation. The Pharmacovigilance system described fulfils the requirements and provides adequate evidence that the applicant has the services of a qualified person responsible for pharmacovigilance and has the necessary means for the identification and notification of any a potential risks occurring either in the Community or in a third country. V. PRODUCT INFORMATION SmPC and Package leaflet The content of the SmPC and package leaflet approved during the decentralised procedure is in accordance with the EU Core Safety Profile for technetium. User consultation The package leaflet has been evaluated via a user consultation study in accordance with the requirements of Articles 59(3) and 61(1) of Directive 2001/83/EC. The language used for the purpose of user testing the PIL was English. The test consisted of: A pilot test with 3 participants, followed by one round with 17 participants. The questions covered the following areas sufficiently: traceability, comprehensibility and applicability. The results show that the package leaflet meets the criteria for readability as set out in the Guideline on the readability of the label and package leaflet of medicinal products for human use. VI. OVERALL CONCLUSION, BENEFIT/RISK ASSESSMENT AND RECOMMENDATION Montek radionuclide generator, 10-40 GBq has a proven chemical-pharmaceutical quality and is a generic form of Drytec. Drytec is a well-known medicinal product with an established favourable efficacy and safety profile. The MAH has provided written confirmation that systems and services are in place to ensure compliance with their pharmacovigilance obligations. The SmPC, package leaflet and labelling are in the agreed templates and are in agreement with the EU Core Safety Profile for technetium. Agreement between Member States was reached during a written procedure.
Load more

Recommended publications
  • Material Safety Data Sheet
    THE CHEM-MET COMPANY – SAFETY DATA SHEET – SODIUM MOLYBDATE DIHYDRATE THE CHEM-MET COMPANY 6419 YOCHELSON PLACE P.O. BOX 819 CLINTON, MARYLAND 20735 (301) 868-3355 FAX (301) 868-3355 SAFETY DATA SHEET SODIUM MOLYBDATE DIHYDRATE PRODUCT INFORMATION DATA SHEET SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier. Substance name: Sodium Molybdate Dihydrate. Chemical formula: Na2MoO4 · 2 H2O. Synonyms/trade names: Sodium Molybdate Dehydrate. Disodium Molybdate Dihydrate. Sodium Molybdate Crystals Index No. (Regulation (EC) No 1272/2008): None. CAS Numbers: 10102-40-6. 7631-95-0 (for the anhydrous Na2MoO4). EC No.: 231-551-7 (assumed to cover both dihydrate and anhydrous form). 1.2. Relevant identified uses of the substance or mixture and uses advised against: 1.2.1. Relevant identified uses: Micronutrient in manufacture and use of fertilizers. Micronutrient in feed additives. Corrosion inhibitor. Manufacture of pigments. Industrial detergent for metal surface treatment. Cleaning & maintenance material. As coolant/anti-freeze/heat transfer fluid. Metal working fluids. Industrial formulation & use of lubrication additives, lubricants and greases. Manufacture of enamels frits, ceramics. Manufacture & use of water treatments chemicals, inc. water softener. Polymer preparations & compounds. Industrial chemical products such as pH regulator, flocculants, precipitants, neutralization agents Extraction agents. Photochemicals. Manufacture and use of catalysts, inc. regeneration & recycling. 1.2.2. Uses advised against: There are no identified uses advised against. 1.3. Details of the supplier of the safety data sheet: THE CHEM-MET COMPANY 6419 YOCHELSON PLACE/ P.O. BOX 819 CLINTON, MARYLAND 20735 USA Tel: 301.868.3355 Fax: 301.868.8946 1 Email: [email protected] (Victor Fox, President); [email protected] (Brendan Hickey, Vice President) THE CHEM-MET COMPANY – SAFETY DATA SHEET – SODIUM MOLYBDATE DIHYDRATE 1.4.
    [Show full text]
  • Category Approaches, Read-Across, (Q)SAR Technical Report No
    Category approaches, Read-across, (Q)SAR Technical Report No. 116 EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS Category approaches, Read-across, (Q)SAR Technical Report No. 116 Brussels, November 2012 ISSN-0773-8072-116 (print) ISSN-2079-1526-116 (online) Category approaches, Read-across, (Q)SAR ECETOC Technical Report No. 116 © Copyright – ECETOC AISBL European Centre for Ecotoxicology and Toxicology of Chemicals 2 Avenue E. Van Nieuwenhuyse (Bte 8), B-1160 Brussels, Belgium. All rights reserved. No part of this publication may be reproduced, copied, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. Applications to reproduce, store, copy or translate should be made to the Secretary General. ECETOC welcomes such applications. Reference to the document, its title and summary may be copied or abstracted in data retrieval systems without subsequent reference. The content of this document has been prepared and reviewed by experts on behalf of ECETOC with all possible care and from the available scientific information. It is provided for information only. ECETOC cannot accept any responsibility or liability and does not provide a warranty for any use or interpretation of the material contained in the publication. ECETOC TR No. 116 Category approaches, Read-across, (Q)SAR Category approaches, Read-across, (Q)SAR TABLE OF CONTENTS SUMMARY 1 1. INTRODUCTION 3 1.1 Terms of reference 4 1.2 Scope 5 1.3 Roadmap of the report 6 2. DEFINITIONS FOR NON-TESTING APPROACHES 8 2.1 Data gap filling 9 2.1.1 Read-across 9 2.1.2 Trend analysis and computational methods based on internal models 13 2.1.3 External (Q)SAR models and expert systems 14 3.
    [Show full text]
  • ANALYSIS of ALTERNATIVES Public Version
    ANALYSIS OF ALTERNATIVES Public Version Legal name of applicant(s): Caffaro Brescia S.r.l. Submitted by: Caffaro Brescia S.r.l. Substance: Sodium dichromate Use title: Use of sodium dichromate as an additive for suppressing parasitic reactions and oxygen evolution, pH buffering and cathode corrosion protection in the electrolytic manufacture of sodium chlorite Use number: 1 Disclaimer This report has been prepared by Risk & Policy Analysts Ltd, with reasonable skill, care and diligence under a contract to the client and in accordance with the terms and provisions of the contract. Risk & Policy Analysts Ltd will accept no responsibility towards the client and third parties in respect of any matters outside the scope of the contract. This report has been prepared for the client and we accept no liability for any loss or damage arising out of the provision of the report to third parties. Any such party relies on the report at their own risk. Note This public version of the Analysis of Alternatives includes some redacted text. The letters indicated within each piece of redacted text correspond to the type of justification for confidentiality claims which is included as an Annex (Section 7) in the complete version of the document. Table of contents 1 Summary..............................................................................................................................1 1.1 Use applied for................................................................................................................................1 1.2 Potential
    [Show full text]
  • Interagency Committee on Chemical Management
    DECEMBER 14, 2018 INTERAGENCY COMMITTEE ON CHEMICAL MANAGEMENT EXECUTIVE ORDER NO. 13-17 REPORT TO THE GOVERNOR WALKE, PETER Table of Contents Executive Summary ...................................................................................................................... 2 I. Introduction .......................................................................................................................... 3 II. Recommended Statutory Amendments or Regulatory Changes to Existing Recordkeeping and Reporting Requirements that are Required to Facilitate Assessment of Risks to Human Health and the Environment Posed by Chemical Use in the State ............................................................................................................................ 5 III. Summary of Chemical Use in the State Based on Reported Chemical Inventories....... 8 IV. Summary of Identified Risks to Human Health and the Environment from Reported Chemical Inventories ........................................................................................................... 9 V. Summary of any change under Federal Statute or Rule affecting the Regulation of Chemicals in the State ....................................................................................................... 12 VI. Recommended Legislative or Regulatory Action to Reduce Risks to Human Health and the Environment from Regulated and Unregulated Chemicals of Emerging Concern ..............................................................................................................................
    [Show full text]
  • ANALYSIS of ALTERNATIVES Public Version
    ANALYSIS OF ALTERNATIVES Public Version Legal name of applicant(s): Kemira Chemicals Oy Submitted by: Kemira Chemicals Oy Substance: Sodium dichromate Use title: Use of sodium dichromate as an additive for suppressing parasitic reactions and oxygen evolution, pH buffering and cathode corrosion protection in the electrolytic manufacture of sodium chlorate with or without subsequent production of chlorine dioxide or sodium chlorite. Use number: 1 Disclaimer This report has been prepared by Risk & Policy Analysts Ltd, with reasonable skill, care and diligence under a contract to the client and in accordance with the terms and provisions of the contract. Risk & Policy Analysis Ltd will accept no responsibility towards the client and third parties in respect of any matters outside the scope of the contract. This report has been prepared for the client and we accept no liability for any loss or damage arising out of the provision of the report to third parties. Any such party relies on the report at their own risk. Note This public version of the Analysis of Alternatives includes some redacted text. The letters indicated within each piece of redacted text correspond to the type of justification for confidentiality claims which is included as an Annex (Section 7) in the complete version of the document. Table of contents 1 Summary..............................................................................................................................1 1.1 Use applied for................................................................................................................................1
    [Show full text]
  • Drowning-Out Crystallization of Sodium Molybdate In
    Available on line at Association of the Chemical Engineers of Serbia AChE Chemical Industry & Chemical Engineering Quarterly www.ache.org.rs/CICEQ Chem. Ind. Chem. Eng. Q. 26 (4) 395−399 (2020) CI&CEQ JESÚS M. CASAS DROWNING-OUT CRYSTALLIZATION OF JOSUÉ LAGOS SODIUM MOLYBDATE IN AQUEOUS– Universidad Técnica Federico –ETHANOL SOLUTIONS Santa María, Valparaíso, Chile Article Highlights SCIENTIFIC PAPER • Sodium molybdate crystallization from aqueous solutions was studied • Sodium molybdate solubility was studied in water-ethanol solutions at 300 K UDC 546.33:546.77:66:661.722 • Na2MoO4 crystallization promoted by ethanol shows low energy and low water consumption Abstract The drowning-out crystallization process of sodium molybdate (Na2MoO4) was studied in water-ethanol solutions at room temperature. Sodium molybdate was separated from the solution in well-crystalline particles using less water and energy compared with the industrial processes that use evaporative crys- tallization. Results showed that crystallization of sodium molybdate di-hydrate was achieved after 20 or 40 min in one or two operating stages for super-satur- ation control with the addition of 25 or 50 vol.% ethanol, respectively. Crystal- lization with ethanol could reduce the operating costs for about 32% with res- pect to the conventional evaporative crystallization method, and the exhausted ethanol in the aqueous solution could be recovered by distillation and then recycled into the process. Keywords: crystallization, drowning-out, ethanol, molybdenum, sodium molybdate. Molybdenum is an element classified as a tran- chemical industry, as catalysts, pigments, thermally sition metal with low concentration (10 mg/t) in nature. stable colouring agents, engine coolants, corrosion Commercial molybdenum recoveries are obtained inhibitors, fertilizer micronutrients, flame and smoke from some massive deposits of molybdenite (MoS2) suppressants, and in semiconductor and electronic ores or from molybdenite concentrates obtained from manufacturing.
    [Show full text]
  • Hydraulic Fracturing Chemicals: Structural Classification, Detections in Flowback Water and Analytical Challenges
    Hydraulic Fracturing Chemicals: Structural Classification, Detections in Flowback Water and Analytical Challenges Dissertation der Mathematisch-Naturwissenschaftlichen Fakultät der Eberhard Karls Universität Tübingen zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) vorgelegt von Kathrin Gabriele Hölzer, geb. Schreglmann aus Weiden i.d. Opf. Tübingen 2016 Tag der mündlichen Qualifikation: 20.07.2016 Dekan: Prof. Dr. Wolfgang Rosenstiel 1. Berichterstatter: PD Dr. Martin Elsner 2. Berichterstatter: Prof. Dr. Christian Zwiener Für Irene und Hermann, in Liebe. Ihr werdet in meiner Erinnerung stets lebendig sein. Table of Contents Hydraulic Fracturing Chemicals: Structural Classification, Detections in Flowback Water and Analytical Challenges .......................................................1 TABLE OF CONTENTS ..........................................................................................................1 SUMMARY ............................................................................................................................5 ZUSAMMENFASSUNG ...........................................................................................................7 1 GENERAL INTRODUCTION ............................................................................................ 9 1.1 Background...........................................................................................................10 1.1.1 Hydraulic Fracturing and Unconventional Gas: Potentials and Environmental Concerns ..............................................................................10
    [Show full text]
  • Food Supplements: Permitted Vitamins and Minerals
    Food Supplements List of Vitamins and Minerals which may be used in the manufacture of food supplements in the EU Digital ISBN 978 0 7504 7646 1 © Crown copyright 2012 WG15822 Important note This document was correct at the time of publishing. The lists of vitamins and minerals permitted for use in food supplements is subject to change. Please ensure you check the European Commission’s website for any amendments to the list (Click here) Vitamins and minerals which may be used in the manufacture of food supplements as permitted by Directive 2002/46/EC relating to food supplements1 Vitamins Unit of Minerals Unit of measurement measurement Vitamin A μg RE Calcium mg Vitamin D μg Magnesium mg Vitamin E mg α-TE Iron mg Vitamin K μg Copper μg Vitamin B1 mg Iodine μg Vitamin B2 mg Zinc mg Niacin mg NE Manganese mg Pantothenic acid mg Sodium mg Vitamin B6 mg Potassium mg Folic acid2 μg Selenium μg Vitamin B12 μg Chromium μg Biotin μg Molybdenum μg Vitamin C mg Fluoride mg Chloride mg Phosphorus mg Boron mg Silicon mg 1 As amended by Regulation (EC) No. 1137/2008 (OJ L311, 21.11.2008, p.1; Regulation (EC) No. 1170/2009 (OJ L314, 1.12.2009, p.36); and Regulation (EC) No. 1161/2011 (OJ L296, 15.11.2011, p.29) 2 Folic acid is the term included in Annex I of Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions for nutrition labelling purposes and covers all forms of folates." Vitamins VITAMIN
    [Show full text]
  • 2019 Trace Minerals
    United States Department of Agriculture Agricultural Marketing Service | National Organic Program Document Cover Sheet https://www.ams.usda.gov/rules-regulations/organic/national-list/petitioned Document Type: ☐ National List Petition or Petition Update A petition is a request to amend the USDA National Organic Program’s National List of Allowed and Prohibited Substances (National List). Any person may submit a petition to have a substance evaluated by the National Organic Standards Board (7 CFR 205.607(a)). Guidelines for submitting a petition are available in the NOP Handbook as NOP 3011, National List Petition Guidelines. Petitions are posted for the public on the NOP website for Petitioned Substances. ☒ Technical Report A technical report is developed in response to a petition to amend the National List. Reports are also developed to assist in the review of substances that are already on the National List. Technical reports are completed by third-party contractors and are available to the public on the NOP website for Petitioned Substances. Contractor names and dates completed are available in the report. Trace Minerals Livestock 1 Identification of Petitioned Substance 2 3 “Trace minerals” is a term for multiple nutritional elements added to livestock, poultry, and companion 4 animal diets in micro quantities only (i.e., measured in milligrams per pound or small units) (AAFCO 5 2019). While the Association of American Feed Control Officials (AAFCO) lists only cobalt, copper, iodine, 6 iron, manganese, and zinc as trace minerals added to animal feeds (AAFCO 2019), this technical report also 7 discusses chromium, molybdenum, and selenium, which are all commonly found in commercial trace 8 mineral products on the market for inclusion in animal feeds.
    [Show full text]
  • Molybdenum and Molybdenum Compounds
    Health Council of the Netherlands Molybdenum and molybdenum compounds Health-based recommended occupational exposure limit Gezondheidsraad Health Council of the Netherlands Aan de minister van Sociale Zaken en Werkgelegenheid Onderwerp : aanbieding advies Molybdenum and molybdenum compounds Uw kenmerk : DGV/MBO/U-932342 Ons kenmerk : U-7988/JR/fs/459-B69 Bijlagen : 1 Datum : 11 december 2013 Geachte minister, Graag bied ik u hierbij aan het advies over de gevolgen van beroepsmatige blootstelling aan molybdeen en molybdeenverbindingen. Dit advies maakt deel uit van een uitgebreide reeks, waarin gezondheidskundige advies- waarden worden afgeleid voor concentraties van stoffen op de werkplek. De conclusies van het genoemde advies zijn opgesteld door de Commissie Gezondheid en beroepsmatige blootstelling aan stoffen (GBBS) van de Gezondheidsraad en beoordeeld door de Beraads- groep Gezondheid en omgeving. Ik heb dit advies vandaag ter kennisname toegezonden aan de staatssecretaris van Infra- structuur en Milieu en aan de minister van Volksgezondheid, Welzijn en Sport. Met vriendelijke groet, prof. dr. W.A. van Gool, voorzitter Bezoekadres Postadres Rijnstraat 50 Postbus 16052 2515 XP Den Haag 2500 BB Den Haag E-mail: [email protected] www.gr.nl Telefoon (070) 340 66 31 Molybdenum and molybdenum compounds Health-based recommended occupational exposure limit Dutch Expert Committee on Occupational Safety, a Committee of the Health Council of the Netherlands to: the Minister of Social Affairs and Employment No. 2013/30, The Hague, November 11, 2013 The Health Council of the Netherlands, established in 1902, is an independent scientific advisory body. Its remit is “to advise the government and Parliament on the current level of knowledge with respect to public health issues and health (services) research...” (Section 22, Health Act).
    [Show full text]
  • Greener Oxidation Reaction
    A Greener Oxidation Reaction A case study prepared by Beyond Benign as part of the Green Chemistry in Higher Education program: A workshop for EPA Region 2 Colleges and Universities A Greener Oxidation Reaction Table of Contents I. Summary Page 3 II. Background Page 3 III. Additional Resources for Green Chemistry in General Chemistry and Beyond Page 4 IV. Traditional Oxidation Reactions Page 5 V. A Greener Oxidation Reaction Page 7 VI. Conclusions and Summary Page 9 VII. Appendix A: Greener Oxidation Laboratory Exercise Page 10 2 A Greener Oxidation Reaction Summary: Oxidation reactions are commonly performed in Reduction in waste and the organic chemistry laboratory course. The reactions are typically performed using chromium purchasing costs: compounds, such as pyridinium chlorochromate For every semester this reaction is (PCC) and sodium dichromate dihydrate, two of implemented with 100 students, there is the most common oxidizing reagents. Chromium an estimated cost savings of $204.46 compounds are known to be carcinogenic and in purchasing and waste disposal costs many also have reproductive and developmental and a decrease in 0.67 gallons liquid hazards associated with them. A greener method and 0.56 pounds solid waste. The for performing this experiment would be very greener version of the Alcohol valuable. Dehydration also results in the elimination in the use of 375 g sodium dichromate dehydrate, 395 mL Background: cyclohexanol and 750 mL diethyl This case study is a result of an EPA Region 2 ether, all of which have human health Source Reduction grant1 titled Green Chemistry in Higher Education: A Workshop for Region 2 Colleges and Universities.
    [Show full text]
  • Nutrient Vitamins and Minerals Handling/Processing
    Nutrient Vitamins and Minerals Handling/Processing 1 Identification of the Petitioned Substances 2 3 This technical report reviews “nutrient vitamins and minerals,” the term which currently appears on the 4 National List at 7 CFR 205.605(b), “Synthetics allowed.” §205.605 relates to “Nonagricultural (nonorganic) 5 substances used as ingredients in or on processed products labeled as “organic” or “made with organic 6 (specified ingredients or food group(s))”. 7 8 The actual “substances used as ingredients in or on processed products” to provide “nutrient vitamins and 9 minerals” are those substances approved or allowed by the Food and Drug Administration (FDA) for 10 addition to food that provide a nutrient in a biologically available form. These are the substances reviewed 11 in this report. 12 13 The U.S. federal organizations responsible for identifying the vitamins and minerals required by humans 14 are the Institute of Medicine (IOM) and the National Research Council (NRC), which periodically review 15 human nutritional science and issue authoritative reports. Between 1997 and 2005, the Food and Nutrition 16 Board and Institute of Medicine published comprehensive reviews of human nutritional requirements, 17 including vitamins and minerals, in the series “Dietary Reference Intakes (DRI)” (Institute of Medicine 18 1997; National Research Council 1998, 2000, 2001, 2005; Institute of Medicine 2011). Consequently, this 19 technical report covers the thirty-plus nutrient vitamins and nutrient minerals mentioned in the DRI 20 reports, as well as inositol, a water-soluble nutrient vitamin required in infant formula, which was 21 reviewed earlier (Food and Nutrition Board 1989). 22 23 In 2012, the National Organic Program (NOP) published a proposed rule1 requesting comments on a change to 24 the annotation for “nutrient vitamins and minerals” to: “For food – vitamins and minerals identified as essential 25 in 21 CFR 101.9.
    [Show full text]